Skip to content

Drug interactions

Efavirenz + Nilotinib

Severity: Major

Efavirenz and Nilotinib: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Nilotinib carries a boxed warning for QT prolongation and sudden death, and efavirenz adds QT risk. Efavirenz also induces CYP3A4 and may lower nilotinib exposure.

What this interaction means in plain words

Efavirenz and Nilotinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Efavirenz belongs to Anti Virals; Nilotinib belongs to Oncology.

Evidence level: Moderate

Why it happens

Additive QT prolongation, plus CYP3A4 induction reducing nilotinib levels.

What to do

Avoid the combination and use an antiretroviral without QT effects or CYP3A induction, such as an integrase inhibitor. If it cannot be avoided, monitor the ECG and electrolytes.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Efavirenz and Nilotinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Efavirenz with Nilotinib?

MediHelp rates the interaction as major. Efavirenz and Nilotinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Nilotinib carries a boxed warning for QT prolongation and sudden death, and efavirenz adds QT risk. Efavirenz also induces CYP3A4 and may lower nilotinib exposure.

How serious is the interaction between Efavirenz and Nilotinib?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination and use an antiretroviral without QT effects or CYP3A induction, such as an integrase inhibitor. If it cannot be avoided, monitor the ECG and electrolytes.

What other medicines interact with Efavirenz?

MediHelp also lists interactions of Efavirenz with, for example, Cobimetinib, Dienogest / estradiol valerate, Dihydroergotamine intranasal. The full list is on the Efavirenz page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in